108 related articles for article (PubMed ID: 16543712)
1. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Stamatelou K; Triantafyllis G; Nicolaou C
Am J Nephrol; 2006; 26(1):91-6. PubMed ID: 16543712
[TBL] [Abstract][Full Text] [Related]
2. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
[TBL] [Abstract][Full Text] [Related]
3. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Zoga M; Alevyzaki F; Stamatelou K; Frangou E; Savva L; Nicolaou C
Nephrology (Carlton); 2006 Dec; 11(6):506-9. PubMed ID: 17199788
[TBL] [Abstract][Full Text] [Related]
4. Telomere Length in Peripheral Blood Mononuclear Cells of Patients on Chronic Hemodialysis Is Related With Telomerase Activity and Treatment Duration.
Stefanidis I; Voliotis G; Papanikolaou V; Chronopoulou I; Eleftheriadis T; Kowald A; Zintzaras E; Tsezou A
Artif Organs; 2015 Sep; 39(9):756-64. PubMed ID: 25894013
[TBL] [Abstract][Full Text] [Related]
5. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
6. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients.
Libetta C; Rampino T; Dal Canton A
Am J Kidney Dis; 2001 Aug; 38(2):286-95. PubMed ID: 11479154
[TBL] [Abstract][Full Text] [Related]
7. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
8. Serum and cellular interleukin-6 in haemodialysis patients: relationship with energy expenditure.
Kamimura MA; Draibe SA; Dalboni MA; Cendoroglo M; Avesani CM; Manfredi SR; Canziani ME; Cuppari L
Nephrol Dial Transplant; 2007 Mar; 22(3):839-44. PubMed ID: 17205966
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
[TBL] [Abstract][Full Text] [Related]
10. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
12. [Telomerase activity of peripheral blood mononuclear cells in patients with acquired immune dysfunction].
Huang Y; Fan X; Zhang Y; Zhou Q; Tang F; Yi H
Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):607-10. PubMed ID: 11798528
[TBL] [Abstract][Full Text] [Related]
13. Effects of different levels of endotoxin contamination on inflammatory cytokine production by peripheral blood mononuclear cells after high-flux hemodialysis.
Praditpornsilpa K; Tiranathanagul K; Susantitaphong P; Katavetin P; Trakarnvanich T; Townamchai N; Kanjanabuch T; Avihingsanon Y; Tungsanga K; Eiam-Ong S
Blood Purif; 2011; 32(2):112-6. PubMed ID: 21447946
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
16. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients.
Tsirpanlis G; Boufidou F; Manganas S; Chantzis K; Bleta A; Stamatelou K; Psimenou E; Nicolaou C
Blood Purif; 2004; 22(6):518-24. PubMed ID: 15557765
[TBL] [Abstract][Full Text] [Related]
17. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
18. Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients.
Tsirpanlis G; Boufidou F; Zoga M; Triantafyllis G; Fatourou A; Stamatelou K; Bleta A; Petrihou C; Chatzipanagiotou S; Nicolaou C
Hemodial Int; 2009 Apr; 13(2):197-204. PubMed ID: 19432694
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients.
Schiavoni G; Di Pietro M; Ronco C; De Cal M; Cazzavillan S; Rassu M; Nicoletti M; Del Piano M; Sessa R
J Biol Regul Homeost Agents; 2010; 24(3):367-75. PubMed ID: 20846485
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
Katayama Y; Kohriyama K
J Rheumatol; 2001 Feb; 28(2):288-91. PubMed ID: 11246663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
